Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
1 other identifier
interventional
92
0 countries
N/A
Brief Summary
This study was designed to investigate the effect of Acupoint stimulation on pain reduction, and fatigue, anxiety and depression and quality of life in Head neck cancer receiving Concurrent Chemoradiotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable head-and-neck-cancer
Started Oct 2016
Shorter than P25 for not_applicable head-and-neck-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2017
CompletedFirst Submitted
Initial submission to the registry
July 11, 2018
CompletedFirst Posted
Study publicly available on registry
August 21, 2018
CompletedAugust 21, 2018
May 1, 2018
1.2 years
July 11, 2018
August 17, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Difference between the two groups from Baseline in Pain Scores on the Visual Analog Scale at 6 Weeks
Pain intensity was assessed using visual analogue scales (VAS) , which is a 10-cm continuous line to assess the subjective perception of pain in the case, with a score of 0 on the leftmost end of the line indicating "painless" and 10 points indicating The "most severe pain" and the reliability of pain assessment , and all participants received this linear tool measurement, recording a total of five
from enrollment to end of treatment at 6 weeks
Secondary Outcomes (3)
Difference between the two groups from Baseline in fatigue on Brief Fatigue Inventory at 6 Weeks
from enrollment to end of treatment at 6 weeks
Difference between the two groups from Baseline in Anxiety and depression on Hospital Anxiety and depression scale
from enrollment to end of treatment at 6 weeks
Difference between the two groups from Baseline in quality of life European organization for research and treatment of cancer quality of life questionnaire head and neck 35(EORTC QLQ-H & N 35)
from enrollment to end of treatment at 6 weeks
Study Arms (2)
Experimental group
EXPERIMENTALTranscutaneous nerve electrical stimulation and Auricular acupressure.
Control group
NO INTERVENTIONwithout intervention
Interventions
Experimental group received Acupoint stimulation, Transcutaneous acupoint electrical stimulation20 minutes/weeks, once a week for six consecutive weeks. The second part of The Experimental group received Auricular acupressure applied to four acupoints, including shenmen (TF2), mouth (IC6), subcortex (CW2), Occiput (AT3). each point is 1min, 5days/week, 3 times/day.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of head and neck cancer with initial concurrent chemoradiotherapy
- Must be able to communicate clearly
- Must be above age 20
You may not qualify if:
- Previous radiotherapy
- History of arrhythmia or use of a pacemaker
- Local swelling or infection over the acupoint area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Chou YH, Yeh ML, Huang TS, Hsu H. Acupoint stimulation improves pain and quality of life in head and neck cancer patients with chemoradiotherapy: A randomized controlled trial. Asia Pac J Oncol Nurs. 2021 Dec 25;9(1):61-68. doi: 10.1016/j.apjon.2021.11.002. eCollection 2022 Jan.
PMID: 35528798DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2018
First Posted
August 21, 2018
Study Start
October 1, 2016
Primary Completion
December 4, 2017
Study Completion
December 4, 2017
Last Updated
August 21, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share